학술논문
UTILITY OF FIB-4, MRE, MRI-PDFF AND FIBROSCAN TO IDENTIFY PATIENTS WITH AT-RISK F2-F3 NASH BASED ON SCREENING DATA FROM A 2000 PATIENT BIOPSY CONFIRMED COHORT OF RESMETIROM PHASE 3 CLINICAL TRIAL, MAESTRO-NASH
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15273350